Skip to main navigation Skip to search Skip to main content

Functional Variation in RGS12 Should Not Preclude Methylphenidate Use in Bipolar Disorder with Established Mood Stabilization: Preclinical Evidence

Fingerprint

Dive into the research topics of 'Functional Variation in RGS12 Should Not Preclude Methylphenidate Use in Bipolar Disorder with Established Mood Stabilization: Preclinical Evidence'. Together they form a unique fingerprint.

Cite this